Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Common Equity (2019 - 2025)

P3 Health Partners (PIII) has disclosed Common Equity for 7 consecutive years, with $44.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Common Equity fell 73.35% year-over-year to $44.5 million, compared with a TTM value of $44.5 million through Jun 2025, down 73.35%, and an annual FY2024 reading of $75.9 million, changed N/A over the prior year.
  • Common Equity was $44.5 million for Q2 2025 at P3 Health Partners, down from $63.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $263.0 million in Q1 2022 and bottomed at -$272.9 million in Q4 2021.
  • Average Common Equity over 5 years is $17.4 million, with a median of $63.2 million recorded in 2025.
  • The sharpest move saw Common Equity tumbled 225.35% in 2023, then soared 5559.81% in 2024.
  • Year by year, Common Equity stood at -$272.9 million in 2021, then skyrocketed by 102.14% to $5.9 million in 2022, then soared by 3110.51% to $187.9 million in 2023, then crashed by 59.6% to $75.9 million in 2024, then tumbled by 41.45% to $44.5 million in 2025.
  • Business Quant data shows Common Equity for PIII at $44.5 million in Q2 2025, $63.2 million in Q1 2025, and $75.9 million in Q4 2024.